Work

Faculty Opinions recommendation of Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Year: 2015

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.725444872.793506737

Author: Alejandro Schaffer

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4238995911

Cites:

Cited by:

Related to: 1